Rational design of drugs that induce human immunodeficiency virus replication

Journal of Virology

Volumn 77, Issue 19, 2003, Pages 10227-10236

  Hamer, Dean H ^a   Bocklandt, Sven ^a   McHugh, Louise ^a   Chun, Tae Wook ^b   Blumberg, Peter M ^a   Sigano, Dina M ^c   Marquez, Victor E ^c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; CD4 ANTIGEN; CELL SURFACE RECEPTOR; CHEMOKINE RECEPTOR CXCR4; DIACYLGLYCEROL DERIVATIVE; IMMUNOTOXIN; LMC 01; LMC 02; LMC 03; LMC 04; LMC 05; LMC 06; LMC 07; LMC 08; LMC 09; LMC 10; PROTEIN KINASE C; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; BINDING KINETICS; CELL CULTURE; CELL KILLING; CONTROLLED STUDY; CORRELATION ANALYSIS; CULTURE MEDIUM; CYTOKINE RELEASE; DOWN REGULATION; DRUG DESIGN; DRUG POTENCY; DRUG STRUCTURE; DRUG TARGETING; ENTROPY; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRUCTURE ANALYSIS; T LYMPHOCYTE ACTIVATION; UPREGULATION; VIRUS EXPRESSION; VIRUS REPLICATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CELL LINE; CYTOKINES; DIGLYCERIDES; DRUG DESIGN; HIV-1; HUMANS; IMMUNOTOXINS; LACTONES; LEUKOCYTES, MONONUCLEAR; PROTEIN KINASE C; RECEPTORS, CXCR4; VIRUS REPLICATION;

EID: 0141856405     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.77.19.10227-10236.2003     Document Type: Article

References (41)

1. Altman, A., and M. Villalba. 2002. Protein kinase C-theta (PKCθ): a key enzyme in T cell life and death. J. Biochem. (Tokyo) 132:841-846.
2. Blankson, J. N., D. Persaud, and R. F. Siliciano. 2002. The challenge of viral reservoirs in HIV-1 infection. Annu. Rev. Med. 53:557-593.
3. Blumberg, P. M., P. Acs, D. K. Bhattacharyya, and P. S. Lorenzo. 2000. Inhibitors of protein kinase C and related receptors for the lipophilic second messenger sn-1,2-diacylglycerol, p. 347-364. In J. S. Gutkind (ed.), Signal transduction and cell cycle inhibitors. Humana Press, Totowa, N.J.
4. Bocklandt, S., P. M. Blumberg, and D. H. Hamer. 2003. Activation of latent HIV-1 expression by the potent anti-tumor promoter 12-deoxyphorbol 13-phenylacetate. Antiviral Res. 59:89-98.
5. Brose, N., and C. Rosenmund. 2002. Move over protein kinase C, you've got company: alternative cellular effectors of diacylglycerol and phorbol esters. J. Cell Sci. 115:4399-4411.
6. + T cells using a combination of cytokines. J. Exp. Med. 188:83-91.
7. + T cells during primary HIV-1 infection. Proc. Natl. Acad. Sci. USA 95:8869-8873.
8. Chun, T. W., and A. S. Fauci. 1999. Latent reservoirs of HIV: obstacles to the eradication of virus. Proc. Natl. Acad. Sci. USA 96:10958-10961.
9. Clouse, K. A., D. Powell, I. Washington, G. Poli, K. Strebel, W. Farrar, P. Barstad, J. Kovacs, A. S. Fauci, and T. M. Folks. 1989. Monokine regulation of human immunodeficiency virus-1 expression in a chronically infected human T cell clone. J. Immunol. 142:431-438.
10. Elsen, M. B., and P. O. Brown. 1999. DNA arrays for analysis of gene expression. Methods Enzymol. 303:179-205.
11. Evans, F. J., and R. J. Schmidt. 1979. The succulent euphorbias of Nigeria. III. Structure and potency of the aromatic ester diterpenes of Euphorbia poissonii Pax. Acta Pharmacol. Toxicol. (Copenhagen) 45:181-191.
12. Folks, T. M., K. A. Clouse, J. Justement, A. Rabson, E. Duh, J. H. Kehrl, and A. S. Fauci. 1989. Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone. Proc. Natl. Acad. Sci. USA 86:2365-2368.
13. Garcia-Bermejo, M. L., F. C. Leskow, T. Fujii, Q. Wang, P. M. Blumberg, M. Ohba, T. Kuroki, K. C. Han, J. Lee, V. E. Marquez, and M. G. Kazanietz. 2002. Diacylglycerol (DAG)-lactones, a new class of protein kinase C (PKC) agonists, induce apoptosis in LNCaP prostate cancer cells by selective activation of PKCα. J. Biol. Chem. 277:645-655.
14. Han, X. M., A. Laras, M. P. Rounseville, A. Kumar, and P. R. Shank. 1992. Human immunodeficiency virus type 1 Tat-mediated trans-activation correlates with the phosphorylation state of a cellular TAR RNA stem-binding factor. J. Virol. 66:4065-4072.
15. Hergenhahn, M., S. Kusumoto, and E. Hecker. 1984. On the active principles of the spurge family (Euphorbiaceae). V. Extremely skin-irritant and moderately tumor-promoting diterpene esters from Euphorbia resinifera Berg. J. Cancer Res. Clin. Oncol. 108:98-109.
16. Ho, D. D. 1998. Toward HIV eradication or remission: the tasks ahead. Science 280:1866-1867.
17. Jakobovits, A., A. Rosenthal, and D. J. Capon. 1990. Trans-activation of HIV-1 LTR-directed gene expression by tat requires protein kinase C. EMBO J. 9:1165-1170.
18. Kagnoff, M. F., and K. A. Roebuck. 1999. Human immunodeficiency virus type 1 (HIV-1) infection and expression in intestinal epithelial cells: role of protein kinase A and C pathways in HIV-1 transcription. J. Infect. Dis. 179(Suppl. 3):S444-S447.
19. Kanashiro, C. A., and R. A. Khalil. 1998. Signal transduction by protein kinase C in mammalian cells. Clin. Exp. Pharmacol. Physiol. 25:974-985.
20. Kazanietz, M. G. 2002. Novel "nonkinase" phorbol ester receptors: the C1 domain connection. Mol. Pharmacol. 61:759-767.
21. Kazanietz, M. G., L. B. Areces, A. Bahador, H. Mischak, J. Goodnight, J. F. Mushinski, and P. M. Blumberg. 1993. Characterization of ligand and substrate specificity for the calcium-dependent and calcium-independent protein kinase C isozymes. Mol. Pharmacol. 44:298-307.
22. Kazanietz, M. G., M. J. Caloca, P. Eroles, T. Fujii, M. L. Garcia-Bermejo, M. Reilly, and H. Wang. 2000. Pharmacology of the receptors for the phorbol ester tumor promoters: multiple receptors with different biochemical properties. Biochem. Pharmacol. 60:1417-1424.
23. Korin, Y. D., D. G. Brooks, S. Brown, A. Korotzer, and J. A. Zack. 2002. Effects of prostratin on T-cell activation and human immunodeficiency virus latency. J. Virol. 76:8118-8123.
24. Kulkosky, J., D. M. Culnan, J. Roman, G. Dornadula, M. Schnell, M. R. Boyd, and R. J. Pomerantz. 2001. Prostratin: activation of latent HIV-1 expression suggests a potential inductive adjuvant therapy for HAART. Blood 98:3006-3015.
25. Kulkosky, J., and R. J. Pomerantz. 2002. Approaching eradication of highly active antiretroviral therapy-persistent human immunodeficiency virus type 1 reservoirs with immune activation therapy. Clin. Infect. Dis. 35:1520-1526.
26. Lee, J., K. C. Han, J. H. Kang, L. L. Pearce, N. E. Lewin, S. Yan, S. Benzaria, M. C. Nicklaus, P. M. Blumberg, and V. E. Marquez. 2001. Conformationally constrained analogues of diacylglycerol. 18. The incorporation of a hydroxamate moiety into diacylglycerol-lactones reduces lipophilicity and helps discriminate between sn-1 and sn-2 binding modes to protein kinase C (PK-C). Implications for isozyme specificity. J. Med. Chem. 44:4309-4312.
27. Marquez, V. E., K. Nacro, S. Benzaria, J. Lee, R. Sharma, K. Teng, G. W. Milne, B. Bienfait, S. Wang, N. E. Lewin, and P. M. Blumberg. 1999. The transition from a pharmacophore-guided approach to a receptor-guided approach in the design of potent protein kinase C ligands. Pharmacol. Ther. 82:251-261.
28. McHugh, L., S. Hu, B. K. Lee, K. Santora, P. E. Kennedy, E. A. Berger, I. Pastan, and D. H. Hamer. 2002. Increased affinity and stability of an anti-HIV-1 envelope immunotoxin by structure based mutagenesis. J. Biol. Chem. 277:34383-34390.
29. Nabel, G., and D. Baltimore. 1987. An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature 326:711-713.
30. Nacro, K., B. Bienfait, J. Lee, K. C. Han, J. H. Kang, S. Benzaria, N. E. Lewin, D. K. Bhattacharyya, P. M. Blumberg, and V. E. Marquez. 2000. Conformationally constrained analogues of diacylglycerol (DAG). 16. How much structural complexity is necessary for recognition and high binding affinity to protein kinase C? J. Med. Chem. 43:921-944.
31. Nacro, K., B. Bienfait, N. E. Lewin, P. M. Blumberg, and V. E. Marquez. 2000. Diacylglycerols with lipophilically equivalent branched acyl chains display high affinity for protein kinase C (PK-C). A direct measure of the effect of constraining the glycerol backbone in DAG lactones. Bioorg. Med. Chem. Lett. 10:653-655.
32. i) with reduced lipophilicity (log P). J. Med. Chem. 44:1892-1904.
33. Pomerantz, R. J. 2002. Reservoirs of human immunodeficiency virus type 1: the main obstacles to viral eradication. Clin. Infect. Dis. 34:91-97.
34. Roebuck, K. A., D. S. Gu, and M. F. Kagnoff. 1996. Activating protein-1 cooperates with phorbol ester activation signals to increase HIV-1 expression. AIDS 10:819-826.
35. Schechtman, D., and D. Mochly-Rosen. 2001. Adaptor proteins in protein kinase C-mediated signal transduction. Oncogene 20:6339-6347.
36. Sigano, D., M. Peach, K. Nacro, Y.-S. Choi, N. E. Lewin, M. C. Nicklaus, P. M. Blumberg, and V. E. Marquez. 2003. Differential binding modes of diacylglycerol (DAG) and DAG-lactones to protein kinase C (PK-C). J. Med. Chem. 46:1571-1579.
37. Sonza, S., and S. M. Crowe. 2001. Reservoirs for HIV infection and their persistence in the face of undetectable viral load. AIDS Patient Care STDS 15:511-518.
38. Szallasi, Z., L. Krsmanovic, and P. M. Blumberg. 1993. Nonpromoting 12-deoxyphorbol 13-esters inhibit phorbol 12-myristate 13-acetate induced tumor promotion in CD-1 mouse skin. Cancer Res. 53:2507-2512.
39. + T cell depletion. J. Clin. Immunol. 21:218-226.
40. Wang, Q. J., D. Bhattacharyya, S. Garfield, K. Nacro, V. E. Marquez, and P. M. Blumberg. 1999. Differential localization of protein kinase C delta by phorbol esters and related compounds using a fusion protein with green fluorescent protein. J. Biol. Chem. 274:37233-37239.
41. Yang, X., Y. Chen, and D. Gabuzda. 1999. ERK MAP kinase links cytokine signals to activation of latent HIV-1 infection by stimulating a cooperative interaction of AP-1 and NF-κB. J. Biol. Chem. 274:27981-27988.